{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:08:07Z","timestamp":1780484887461,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":546,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007659","name":"Bayer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Kabushiki Kaisha","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004095","name":"Kyowa Kirin Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002975","name":"Sumitomo Pharma Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010795","name":"Chugai Seiyaku Kabushiki Kaisha","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009954","name":"Taiho Pharmaceutical Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004169","name":"Meiji Seika Pharma Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004169","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.exphem.2024.104636","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T02:32:53Z","timestamp":1725417173000},"page":"104636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Involvement of CREB3L1 in erythropoiesis induced by JAK2 exon 12 mutation"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0815-7860","authenticated-orcid":false,"given":"Maho","family":"Okuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3502-5000","authenticated-orcid":false,"given":"Marito","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0376-663X","authenticated-orcid":false,"given":"Federico","family":"De Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soji","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5192-5957","authenticated-orcid":false,"given":"Misa","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanaka","family":"Fukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8871-1330","authenticated-orcid":false,"given":"Miki","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1880-9126","authenticated-orcid":false,"given":"Norio","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2024.104636_bib0001","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2016-10-695940","article-title":"Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms","volume":"129","author":"Vainchenker","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104636_bib0002","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood.2022017578","article-title":"Genetic basis and molecular profiling in myeloproliferative neoplasms","volume":"141","author":"Luque Paz","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104636_bib0003","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006098","article-title":"Signal transduction in cancer","volume":"5","author":"Sever","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.exphem.2024.104636_bib0004","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/cas.14763","article-title":"CREB3L1 overexpression as a potential diagnostic marker of Philadelphia chromosome-negative myeloproliferative neoplasms","volume":"112","author":"Morishita","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.exphem.2024.104636_bib0005","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ncb1213","article-title":"OASIS, a CREB\/ATF-family member, modulates UPR signalling in astrocytes","volume":"7","author":"Kondo","year":"2005","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2024.104636_bib0006","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1471-4159.2005.03596.x","article-title":"Cleavage of the membrane-bound transcription factor OASIS in response to endoplasmic reticulum stress","volume":"96","author":"Murakami","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.exphem.2024.104636_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124956","article-title":"Transcription factor CREB3L1 regulates endoplasmic reticulum stress response genes in the osmotically challenged rat hypothalamus","volume":"10","author":"Greenwood","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2024.104636_bib0008","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1471-4159.2009.06188.x","article-title":"Increased vulnerability of hippocampal pyramidal neurons to the toxicity of kainic acid in OASIS-deficient mice","volume":"110","author":"Chihara","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.exphem.2024.104636_bib0009","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/hmg\/ddz017","article-title":"A homozygous pathogenic missense variant broadens the phenotypic and mutational spectrum of CREB3L1-related osteogenesis imperfecta","volume":"28","author":"Guillemyn","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.exphem.2024.104636_bib0010","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41467-017-01052-y","article-title":"Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1","volume":"8","author":"Feng","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2024.104636_bib0011","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/ncb1963","article-title":"Signalling mediated by the endoplasmic reticulum stress transducer OASIS is involved in bone formation","volume":"11","author":"Murakami","year":"2009","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2024.104636_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2022.106883","article-title":"Clinical and biological relevance of CREB3L1 in Philadelphia chromosome-negative myeloproliferative neoplasms","volume":"119","author":"De Marchi","year":"2022","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2024.104636_bib0013","doi-asserted-by":"crossref","first-page":"156","DOI":"10.7150\/ijms.6.156","article-title":"Gene expression analysis of human red blood cells","volume":"6","author":"Kabanova","year":"2009","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.exphem.2024.104636_bib0014","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1186\/s12864-015-2156-2","article-title":"A comprehensive joint analysis of the long and short RNA transcriptomes of human erythrocytes","volume":"16","author":"Doss","year":"2015","journal-title":"BMC Genomics"},{"key":"10.1016\/j.exphem.2024.104636_bib0015","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.3324\/haematol.2014.115113","article-title":"JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasms","volume":"100","author":"Shirane","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2024.104636_bib0016","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s12185-014-1567-1","article-title":"JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan","volume":"99","author":"Edahiro","year":"2014","journal-title":"Int J Hematol"},{"key":"10.1016\/j.exphem.2024.104636_bib0017","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s12185-018-2421-7","article-title":"Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms","volume":"107","author":"Misawa","year":"2018","journal-title":"Int J Hematol"},{"key":"10.1016\/j.exphem.2024.104636_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104958","article-title":"Detection of MPLW515L\/K mutations and determination of allele frequencies with a single-tube PCR assay","volume":"9","author":"Takei","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2024.104636_bib0019","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104636_bib0020","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/cam4.4958","article-title":"Clinical features of acquired erythrocytosis: low levels of serum erythropoietin in a subset of non-neoplastic erythrocytosis patients","volume":"12","author":"Mori","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.exphem.2024.104636_bib0021","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41467-018-02866-0","article-title":"Single-cell full-length total RNA sequencing uncovers dynamics of recursive splicing and enhancer RNAs","volume":"9","author":"Hayashi","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2024.104636_bib0022","doi-asserted-by":"crossref","first-page":"17702","DOI":"10.1038\/s41598-021-97106-9","article-title":"Cell-autonomous megakaryopoiesis associated with polyclonal hematopoiesis in triple-negative essential thrombocythemia","volume":"11","author":"Inano","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.exphem.2024.104636_bib0023","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/bjh.15266","article-title":"Skewed megakaryopoiesis in human induced pluripotent stem cell-derived haematopoietic progenitor cells harbouring calreticulin mutations","volume":"181","author":"Takei","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2024.104636_bib0024","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1182\/blood-2015-09-671172","article-title":"Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms","volume":"127","author":"Araki","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104636_bib0025","doi-asserted-by":"crossref","first-page":"e57633","DOI":"10.1371\/journal.pone.0057633","article-title":"Inhibition of the NAD-dependent protein deacetylase SIRT2 induces granulocytic differentiation in human leukemia cells","volume":"8","author":"Sunami","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.exphem.2024.104636_bib0026","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1182\/blood-2010-11-316810","article-title":"Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations","volume":"117","author":"Passamonti","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104636_bib0027","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1172\/JCI105674","article-title":"Hemoglobin Yakima: I. clinical and biochemical studies","volume":"46","author":"Jones","year":"1967","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2024.104636_bib0028","doi-asserted-by":"crossref","first-page":"406","DOI":"10.7326\/0003-4819-109-5-406","article-title":"Adults with cyanotic congenital heart disease: hematologic management","volume":"109","author":"Perloff","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.exphem.2024.104636_bib0029","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/2643-3230.BCD-21-0192","article-title":"Amplified EPOR\/JAK2 genes define a unique subtype of acute erythroid leukemia","volume":"3","author":"Takeda","year":"2022","journal-title":"Blood Cancer Discov"},{"key":"10.1016\/j.exphem.2024.104636_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101542","article-title":"Transcription factor Creb3l1 maintains proteostasis in neuroendocrine cells","volume":"63","author":"Greenwood","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/j.exphem.2024.104636_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112479","article-title":"p53-Independent tumor suppression by cell-cycle arrest via CREB\/ATF transcription factor OASIS","volume":"42","author":"Saito","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2024.104636_bib0032","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.chom.2011.06.006","article-title":"The membrane-bound transcription factor CREB3L1 is activated in response to virus infection to inhibit proliferation of virus-infected cells","volume":"10","author":"Denard","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.exphem.2024.104636_bib0033","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3390\/cancers11081112","article-title":"p21cip1\/waf1 coordinate autophagy, proliferation and apoptosis in response to metabolic stress","volume":"11","author":"Manu","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.exphem.2024.104636_bib0034","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1101\/gad.8.4.453","article-title":"CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1\/S arrest","volume":"8","author":"Barone","year":"1994","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2024.104636_bib0035","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1182\/blood-2010-07-290825","article-title":"Global gene expression analysis of human erythroid progenitors","volume":"117","author":"Merryweather-Clarke","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104636_bib0036","doi-asserted-by":"crossref","first-page":"14317","DOI":"10.1073\/pnas.250488697","article-title":"Reprogramming leukemic cells to terminal differentiation by inhibiting specific cyclin-dependent kinases in G1","volume":"97","author":"Matushansky","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.exphem.2024.104636_bib0037","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1182\/blood.V93.10.3369.410k11_3369_3378","article-title":"Regulated expression and functional role of the transcription factor CHOP (GADD153) in erythroid growth and differentiation","volume":"93","author":"Coutts","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104636_bib0038","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/leu.2017.1","article-title":"Activating JAK2 mutants reveal cytokine receptor coupling differences that impact outcomes in myeloproliferative neoplasm","volume":"31","author":"Yao","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2024.104636_bib0039","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa065202","article-title":"JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis","volume":"356","author":"Scott","year":"2007","journal-title":"N Engl J Med"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X24005010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X24005010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:04:01Z","timestamp":1777640641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X24005010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":39,"alternative-id":["S0301472X24005010"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2024.104636","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of CREB3L1 in erythropoiesis induced by JAK2 exon 12 mutation","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2024.104636","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Experimental Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104636"}}